Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcutis Biotherapeutics (ARQT) Non Operating Income (2020 - 2025)

Arcutis Biotherapeutics (ARQT) has 6 years of Non Operating Income data on record, last reported at -$6.4 million in Q4 2025.

  • For Q4 2025, Non Operating Income rose 52.13% year-over-year to -$6.4 million; the TTM value through Dec 2025 reached $443000.0, up 842.55%, while the annual FY2025 figure was $443000.0, 842.55% up from the prior year.
  • Non Operating Income reached -$6.4 million in Q4 2025 per ARQT's latest filing, down from $2.0 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $5.2 million in Q2 2024 and bottomed at -$13.4 million in Q4 2024.
  • Average Non Operating Income over 5 years is -$57300.0, with a median of $121000.0 recorded in 2022.
  • The widest YoY moves for Non Operating Income: up 8400.0% in 2022, down 3121.43% in 2022.
  • A 5-year view of Non Operating Income shows it stood at -$40000.0 in 2021, then skyrocketed by 8400.0% to $3.3 million in 2022, then plummeted by 303.58% to -$6.8 million in 2023, then plummeted by 98.37% to -$13.4 million in 2024, then soared by 52.13% to -$6.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non Operating Income were -$6.4 million in Q4 2025, $2.0 million in Q3 2025, and $2.1 million in Q2 2025.